Alaunos Therapeutics, Inc.
TCRTNasdaqHealthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $5,000 | $10,000 | $5,000 | $2.9M | $398,000 | $0 |
| Operating income | −$4.2M | −$4.8M | −$34.3M | −$35.1M | −$77.5M | −$18.7M |
| Net income | −$4.2M | −$4.7M | −$4.7M | −$37.7M | −$78.8M | −$18.3M |
| Total assets | $3.0M | $2.8M | $8.3M | $64.9M | $94.9M | $146.3M |
| Total liabilities | $813,000 | $692,000 | $2.0M | $26.4M | $36.8M | $22.4M |
| Equity | $2.2M | $2.1M | $6.3M | $38.6M | $58.1M | $124.0M |
| EPS (diluted) | $-2.20 | $-2.92 | $-21.97 | $-2.61 | $-0.37 | $-0.09 |
| Shares out. | 1.6M | 16.0M | 240.6M | 216.1M | 214.7M | 213.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −84500.0%
- Net margin
- −83520.0%
- Return on equity
- −194.0%
- Return on assets
- −140.8%
- Return on capital (ROCE)
- −196.2%
- Liabilities / assets
- 27.4%
- Debt / equity
- 0.38×
- Book value / share
- $1.34
- Revenue growth (YoY)
- −50.0%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -1020.47distress
- Accruals / assets
- −44.1%clean
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 4 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Aug 9, 2021
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Price AdrianActivist (13D)Mar 5, 2026
- Strategic Ep, LlcPassive (13G)Oct 16, 2025
- Pmgc Capital LlcActivist (13D)Sep 5, 2025
- Postma Robert WActivist (13D)Jul 1, 2025
- Msd Partners, L.P.Passive (13G)Feb 13, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 7,893 | 1.0 | -9.4% |
| Apr 30, 2026 | 8,714 | 1.0 | -29.6% |
| Apr 15, 2026 | 12,380 | 1.0 | -12.6% |
| Mar 31, 2026 | 14,162 | 1.0 | +4.7% |
| Mar 13, 2026 | 13,529 | 1.0 | -60.5% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Other material eventMay 26, 2026
- Other material eventMay 18, 2026
- Delisting / listing-standard noticeApr 15, 2026
- Other material eventMar 2, 2026
- Terminated a material agreement · Modified shareholder rights · Other material eventJan 8, 2026
- Other material eventDec 23, 2025
- Other material eventAug 20, 2025
- Director / officer changeJul 22, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.